A Study of Quizartinib Pharmacokinetics in Participants With Moderate Hepatic Impairment

Clinical trial NCT04473664 · COMPLETED

Trial details

NCT number: NCT04473664
Sponsor: Daiichi Sankyo
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment Moderate Impaired Hepatic Function

Start date: 2020-09-22
Primary completion: 2021-07-22
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.